Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Manappuram Finance, Rossari Biotech shares trade ex-dividend today

    May 24, 2023

    Scottish Biotech ILC Therapeutics Signs R&D Partnership With Dechra Pharmaceuticals PLC

    May 23, 2023

    Israeli biotech phenom puts death knell on cancer

    May 22, 2023
    Facebook Twitter Instagram
    Your Biotech
    • Bio Technology

      Manappuram Finance, Rossari Biotech shares trade ex-dividend today

      May 24, 2023

      Scottish Biotech ILC Therapeutics Signs R&D Partnership With Dechra Pharmaceuticals PLC

      May 23, 2023

      Israeli biotech phenom puts death knell on cancer

      May 22, 2023

      Six Norwegian companies leading the country’s biotech scene

      May 19, 2023

      Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data

      May 18, 2023
    • Pharmaceutical

      Pharma company owner duped of ₹1.1 crore

      November 11, 2022

      Novavax cuts full-year revenue forecast again amid weak demand

      November 10, 2022

      Aurobindo units recall products in US market for manufacturing issues

      November 9, 2022

      AASLD 2022 | Ascentage Pharma Releases Phase I Results of IAP Antagonist APG-1387 in an Oral Report Showing Potential for Functionally Curing CHB

      November 8, 2022

      Trade Spotlight | What should you do with Amara Raja, Sun Pharma Advanced Research, Poly Medicure on Monday?

      November 7, 2022
    Your Biotech
    Home»Bio Technology»IHF funds two biotech platforms to diagnose mosquito-borne diseases 
    Bio Technology

    IHF funds two biotech platforms to diagnose mosquito-borne diseases 

    yourbiotechBy yourbiotechFebruary 22, 2023Updated:February 22, 2023No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    A Tata Trusts initiative, the India Health Fund (IHF), has funded two platforms that have been developed to help diagnose multiple diseases.  The first innovation developed by Ameliorate Biotech is a fever panel to detect dengue, chikungunya, and malaria; the other by Medprime Technologies is a microscope-agnostic Artificial Intelligence (AI)-enabled diagnosis software that is applicable across diseases, a note on the development said. 

    d diagnostic test

    “There is an immediate need for a real-time, simple-to-use, affordable, user-friendly, and equipment-free rapid diagnostic test (RDT). “Similarly, an algorithm that can quickly and accurately diagnose diseases like malaria without the subjectivity that comes with variation in microscopist skills and training is invaluable to remote communities,” according to the note. Cases of mosquito-borne diseases such as dengue and chikungunya have increased between 2015 and 2021. While malaria prevalence has decreased over the last 20 years, absolute numbers remain high, according to the report, which also notes that the illnesses frequently present similar symptoms at an early stage, which can lead to misdiagnosis or even delayed diagnosis.

    Ameliorate Biotech platform

    The Ameliorate Biotech platform includes an accurate, multiplexed RDT for dengue, chikungunya, and malaria (with malaria falciparum and vivax differentiation), a simple 15-minute test that uses a single test kit and a single blood sample, and can be easily used by minimally trained primary-level workers. The process eliminates the need for serum/plasma samples, is instantaneous, does not require a cold chain facility or a biosafety lab, and generates minimal medical waste. The note elaborated. The IHF funding will enable prospective, multicentric performance and cost-effectiveness evaluation of the RDT, which will be made available for government procurements at a discounted price of $200 per piece. This is less than the current fever panel price of $3000-4000, according to the company. Medprime Technologies’ platform includes artificial intelligence-powered software for

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleIHF announces funding for diagnostic innovations by Ameliorate Biotech and Medprime Technologies
    Next Article 12 conditions from Alzheimer’s to Lyme that Mass. biotechs are developing treatments for now
    yourbiotech
    • Website

    Related Posts

    Manappuram Finance, Rossari Biotech shares trade ex-dividend today

    May 24, 2023

    Scottish Biotech ILC Therapeutics Signs R&D Partnership With Dechra Pharmaceuticals PLC

    May 23, 2023

    Israeli biotech phenom puts death knell on cancer

    May 22, 2023

    Six Norwegian companies leading the country’s biotech scene

    May 19, 2023

    Leave A Reply Cancel Reply

    Our Picks

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us
    About Us

    We provide a wide range of customized, integrated B2B and B2C digital marketing services solutions that are ideal for your business.

    We're accepting new partnerships right now.

    Email Us: info@yourmartech.com
    Contact: +1-530-518-1420

    Our Brands
    • Your Martech
    • Your HR Tech
    • Your Fin Tech
    • Your Revenue
    • Your Info Tech
    • Your POS Tech
    • Your Health Tech
    SUBSCRIBE NOW
    Loading
    LinkedIn
    • Privacy Policy
    © 2022 Vigarbiz Inc. Designed by Vigarbiz Media

    Type above and press Enter to search. Press Esc to cancel.